Why the study?
Does aspirin reduce recurrent myocardial infarction and death in patients with MI or unstable angina?
Population
Patients with myocardial infarction (MI) or unstable angina
Comparison
Aspirin 325 mg once daily vs Placebo
Design
Review
Authors
Loading...
Supports aspirin 325 mg daily for secondary prevention post-MI; leaves open need for updated RCTs in contemporary populations.
Does aspirin reduce recurrent myocardial infarction and death in patients with MI or unstable angina?
Aspirin 325 mg daily is an effective and well-tolerated therapy for the secondary prevention of recurrent MI and death in patients with a history of MI or unstable angina.
Rumore et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: